Genotype-phenotype relationships in patients with type i hyperlipoproteinemia

Journal of Clinical Lipidology

Volumn 8, Issue 3, 2014, Pages 287-295

  Chokshi, Neema ^a   Blumenschein, Sarah D ^b   Ahmad, Zahid ^a   Garg, Abhimanyu ^a  

^a Center for Human Nutrition   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein A5; Familial chylomicronemia syndrome; GPIHBP1; Keywords; Lipoprotein lipase; Type 1 hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN C2; FENOFIBRATE; FENOFIBRIC ACID; FISH OIL; GEMFIBROZIL; GLYCOSYL PHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; INSULIN; LEVOTHYROXINE; LIPOPROTEIN LIPASE; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; ORAL CONTRACEPTIVE AGENT; SIMVASTATIN; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; GPIHBP1 PROTEIN, HUMAN; LIPOPROTEIN RECEPTOR; LMF1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ADULT; ANEMIA; ARTICLE; BODY MASS; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONSANGUINITY; DIARRHEA; DRUG CAPSULE; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEMOGLOBIN DETERMINATION; HEPATOMEGALY; HEPATOSPLENOMEGALY; HISPANIC; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INDIAN; INSULIN TREATMENT; LETHARGY; LIPID DIET; LOW FAT DIET; MALE; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; NAUSEA AND VOMITING; OPHTHALMOSCOPY; PHENOTYPIC VARIATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; YOUNG ADULT; CASE REPORT; DIET THERAPY; GENETIC ASSOCIATION; GENETICS; METABOLISM; SEX DIFFERENCE;

ADOLESCENT; ADULT; APOLIPOPROTEIN C-II; APOLIPOPROTEINS A; CHILD; CHILD, PRESCHOOL; DIET THERAPY; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; LIPOPROTEIN LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, LIPOPROTEIN; SEX FACTORS; YOUNG ADULT;

EID: 84899719084     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.02.006     Document Type: Article

References (44)

1. J.D. Brunzell Clinical practice. Hypertriglyceridemia N Engl J Med 357 2007 1009 1017
2. M.R. Fortson, S.N. Freedman, and P.D. Webster 3rd Clinical assessment of hyperlipidemic pancreatitis Am J Gastroenterol 90 1995 2134 2139
3. P.A. Banks, and M.L. Freeman Practice guidelines in acute pancreatitis Am J Gastroenterol 101 2006 2379 2400
4. B. Gloor, C.A. Muller, M. Worni, M.E. Martignoni, W. Uhl, and M.W. Buchler Late mortality in patients with severe acute pancreatitis Br J Surg 88 2001 975 979
5. C.F. Cheng, G.M. Oosta, A. Bensadoun, and R.D. Rosenberg Binding of lipoprotein lipase to endothelial cells in culture J Biol Chem 256 1981 12893 12898
6. J.D. Brunzell, and S.S. Deeb Familial lipoprotein lipase deficiency, Apo C-II deficiency, and hepatic lipase deficiency C.R. Scriver, B.L. Beaudet, W.S. Sly, D. Valle, The Metabolic and Molecular Bases of Inherited Disease 2006 The McGraw-Hill Companies New York
7. M. Peterfy, O. Ben-Zeev, and H.Z. Mao et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia Nat Genet 39 2007 1483 1487
8. J. Wang, and R.A. Hegele Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650) Lipids Health Dis 6 2007 23
9. A.P. Beigneux, R. Franssen, and A. Bensadoun et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase Arterioscler Thromb Vasc Biol 29 2009 956 962
10. C. Priore Oliva, F. Carubbi, F.G. Schaap, S. Bertolini, and S. Calandra Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene J Intern Med 263 2008 450 458
11. C. Marcais, B. Verges, and S. Charriere et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment J Clin Invest 115 2005 2862 2869
12. C. Priore Oliva, L. Pisciotta, and G. Li Volti et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia Arterioscler Thromb Vasc Biol 25 2005 411 417
13. C. Priore Oliva, P. Tarugi, and S. Calandra et al. A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia Atherosclerosis 188 2006 215 217
14. M. Peterfy Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism Biochim Biophys Acta 1821 2012 790 794
15. B.S. Davies, A.P. Beigneux, and R.H. Barnes 2nd et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries Cell Metab 12 2010 42 52
16. A.P. Beigneux, B.S. Davies, and P. Gin et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons Cell Metab 5 2007 279 291
17. S.K. Nilsson, J. Heeren, G. Olivecrona, and M. Merkel Apolipoprotein A-V: a potent triglyceride reducer Atherosclerosis 219 2011 15 21
18. G. Baggio, E. Manzato, and C. Gabelli et al. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients J Clin Invest 77 1986 520 527
19. F.U. Beil, S.S. Fojo, H.B. Brewer Jr., H. Greten, and U. Beisiegel Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism Eur J Clin Invest 22 1992 88 95
20. W.C. Breckenridge, P. Alaupovic, D.W. Cox, and J.A. Little Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency Atherosclerosis 44 1982 223 235
21. W.C. Breckenridge, J.A. Little, G. Steiner, A. Chow, and M. Poapst Hypertriglyceridemia associated with deficiency of apolipoprotein C-II N Engl J Med 298 1978 1265 1273
22. D.W. Cox, W.C. Breckenridge, and J.A. Little Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis N Engl J Med 299 1978 1421 1424
23. R. Fellin, G. Baggio, and A. Poli et al. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives Atherosclerosis 49 1983 55 68
24. S.S. Fojo, G. Baggio, and C. Gabelli et al. Apolipoprotein C-II deficiency: identification of a structural variant ApoC-II Padova Biochem Biophys Res Commun 154 1988 73 79
25. S.S. Fojo, J.L. de Gennes, and J. Chapman et al. An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II J Biol Chem 264 1989 20839 20842
26. S.S. Fojo, P. Lohse, and C. Parrott et al. A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency J Clin Invest 84 1989 1215 1219
27. S.S. Fojo, A.F. Stalenhoef, K. Marr, R.E. Gregg, R.S. Ross, and H.B. Brewer Jr. A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II J Biol Chem 263 1988 17913 17916
28. M. Kawano, K. Kodama, and H. Inadera et al. A case of apolipoprotein C-II deficiency with coronary artery disease Clin Exp Med 2 2002 29 31
29. M. Ohno, S. Ishibashi, and K. Nakao et al. A neonatal case of apolipoprotein C-II deficiency Eur J Pediatr 148 1989 550 552
30. M. Okubo, Y. Hasegawa, Y. Aoyama, and T. Murase A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient Atherosclerosis 130 1997 153 160
31. S. Takase, J. Osuga, and H. Fujita et al. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene J Atheroscler Thromb 20 2013 481 493
32. C.J. Wilson, C. Priore Oliva, F. Maggi, A.L. Catapano, and S. Calandra Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy Ann Neurol 53 2003 807 810
33. T. Yamamura, H. Sudo, K. Ishikawa, and A. Yamamoto Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency Atherosclerosis 34 1979 53 65
34. J.J. Rios, S. Shastry, and J. Jasso et al. Deletion of GPIHBP1 causing severe chylomicronemia J Inherit Metab Dis 35 2012 531 540
35. A.B. Cefalu, D. Noto, and M.L. Arpi et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia J Clin Endocrinol Metab 94 2009 4584 4590
36. S.P. Babirak, P.H. Iverius, W.Y. Fujimoto, and J.D. Brunzell Detection and characterization of the heterozygote state for lipoprotein lipase deficiency Arteriosclerosis 9 1989 326 334
37. J.C. Feoli-Fonseca, E. Levy, M. Godard, and M. Lambert Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study J Pediatr 133 1998 417 423
38. P. Benlian, J.L. De Gennes, L. Foubert, H. Zhang, S.E. Gagne, and M. Hayden Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene N Engl J Med 335 1996 848 854
39. Y. Saika, N. Sakai, and M. Takahashi et al. Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis Eur J Clin Invest 33 2003 216 222
40. H. Yamamoto, M. Onishi, and N. Miyamoto et al. Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD J Atheroscler Thromb 20 2013 777 784
41. M.M. Weinstein, L. Yin, and A.P. Beigneux et al. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice J Biol Chem 283 2008 34511 34518
42. R. Franssen, S.G. Young, and F. Peelman et al. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects Circ Cardiovasc Genet 3 2010 169 178
43. G. Olivecrona, E. Ehrenborg, and H. Semb et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia J Lipid Res 51 2010 1535 1545
44. D. Gaudet, J. Methot, and S. Dery et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial Gene Ther 20 2013 361 369